New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2013
05:55 EDTADUS, ADUS, ATRS, ATRS, BGMD, BGMD, DSCO, DSCO, EXPR, EXPR, GSOL, GSOL, KOPN, KOPN, PERI, PERI, SNSS, SNSSCompanies reporting Before the Market Open on Wednesday, March 13
Notable companies reporting before the opening bell on Wednesday include Addus Homecare (ADUS), Antares Pharma (ATRS), BG Medicine (BGMD), Discovery Laboratories (DSCO), Express (EXPR), Global Sources (GSOL), Kopin (KOPN), Perion Network (PERI), and Sunesis Pharmaceuticals (SNSS).
Sign up for a free trial to see the rest of the stories you've been missing.
July 1, 2015
07:37 EDTDSCODiscovery Labs notified by NASDAQ of minimum bid price requirement noncompliance
Discovery Laboratories received a letter from The Nasdaq Stock Market indicating that, because the company's common stock has not maintained a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, the company is no longer in compliance with Nasdaq's Minimum Bid Price Requirement Listing Rule. The company has until December 28 to regain compliance with the Requirement. If during the grace period, the company's common stock achieves a minimum closing bid price of at least $1.00 per share for a period of at least ten consecutive business days, the company will regain compliance with the Minimum Bid Price Requirement and its common stock will continue to be eligible for listing on the Nasdaq Capital Market. The company may be eligible for an additional grace period through June 27, 2016.
05:18 EDTGSOLGlobal Sources sells eMedia subsidiary
Global Sources has sold its 60.1% interest in its eMedia Asia Limited subsidiary to UBM plc, the 39.9% shareholder, for approximately $9.0M in cash subject to adjustments for cash and working capital.
June 22, 2015
08:35 EDTKOPNKopin divests interest in Recon Instruments
Kopin (KOPN) said it had divested its equity interest in Recon Instruments as part of Intel Corporationís (INTC) acquisition of Recon. Kopin anticipates that it will receive approximately $6M in cash proceeds for its equity interest, subject to certain closing conditions including a working capital adjustment.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use